LF
GSK icon

Lantz Financial’s GSK GSK Stock Holding History

Lantz Financial’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$208K Buy
3,970
+98
+3% +$5.18K 0.04% 253
2026
Q1 		$214K Sell
3,872
-4,486
-54% -$243K 0.04% 232
2025
Q4 		$410K Sell
8,358
-2,257
-21% -$105K 0.09% 185
2025
Q3 		$458K Buy
10,615
+484
+5% +$18.9K 0.1% 164
2025
Q2 		$389K Buy
+10,131
New +$387K 0.1% 163
2020
Q3 		– Sell
-4,162
Closed -$212K – 121
2020
Q2 		$212K Sell
4,162
-2,010
-33% -$103K 0.15% 104
2020
Q1 		$292K Sell
6,172
-401
-6% -$21.4K 0.23% 88
2019
Q4 		$386K Sell
6,573
-477
-7% -$26.5K 0.23% 95
2019
Q3 		$363K Sell
7,050
-15
-0.2% -$772 0.25% 95
2019
Q2 		$361K Sell
7,065
-4,941
-41% -$248K 0.24% 94
2019
Q1 		$627K Buy
+12,006
New +$600K 0.45% 63

Other funds holding GSK

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.82B AUM
AA
ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return
SIS
Sound Income Strategies Ft Lauderdale, Florida $2.23B AUM 11.22% 1-Year Est. Return
KFP
Keystone Financial Planning Cleveland, Ohio $388M AUM 16.66% 1-Year Est. Return
QCM
QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return
TH
Transmarket Holdings Chicago, Illinois $136M AUM
GC
Grimes & Company Westborough, Massachusetts $4.62B AUM 29.71% 1-Year Est. Return
BB
Bell Bank Fargo, North Dakota $2.62B AUM 23.93% 1-Year Est. Return

Lantz Financial's GSK Position: Q2 2026 in Review

Lantz Financial increased its GSK (GSK) stake by 2.5% in Q2 2026, buying an estimated $5.18K and bringing the position to 3,970 shares worth $208K. The position accounts for 0.04% of the portfolio, ranked #253.

Lantz Financial first reported a position in GSK in Q1 2019 and has held it in 11 quarters since. The position peaked at $627K in Q1 2019. 213 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Lantz Financial held 3,970 shares of GSK worth $208K as of Q2 2026.
  • Lantz Financial bought 98 GSK shares in Q2 2026, an estimated $5.18K.
  • GSK made up 0.04% of Lantz Financial's portfolio in Q2 2026, its #253 holding.
  • Lantz Financial first reported a position in GSK in Q1 2019 and has held it in 11 quarters since.
  • Lantz Financial's GSK position peaked at $627K in Q1 2019.
  • 213 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Lantz Financial's 13F filing for Q2 2026, filed 9 Jul 2026.